Engineered Defensin-Albumin Fusion Protein Suppresses Cytokine Storms and Reduces Organ Damage in Mice | Research

The takeaway

A fusion protein combining two human beta-defensin 2 molecules with albumin (DF2-HSA) reduced mortality, cytokine levels, vascular leakage, and lung/intestine damage in a cytokine storm mouse model.

Dual action
DF2-HSA combines HBD-2 antimicrobial activity with albumin's anti-inflammatory properties in a single long-acting molecule

What the researchers found

DF2-HSA reduced mortality in a cytokine storm mouse model while prolonging HBD-2 retention, decreasing multiple inflammatory cytokines, reducing vascular leakage, and alleviating lung and intestinal tissue damage.

Why it matters

Cytokine storms remain a major cause of death in sepsis and severe viral infections. An engineered defensin that both fights infection and controls inflammation could address both aspects simultaneously.

How the study worked

LPS-induced cytokine storm model in BALB/c athymic mice, with Luminex cytokine profiling, Evans blue vascular permeability assay, transmission electron microscopy, and histopathological analysis.

What this study cannot tell us

Mouse model using athymic mice. LPS-induced cytokine storm may not fully replicate human sepsis or viral-induced storms. Dosing optimization and safety profiling needed.

How to read the evidence

Preclinical study with comprehensive outcome assessment. Novel fusion protein approach but needs validation in more clinically relevant models.

When this study was published

Published in 2025.

The bigger picture

This fusion protein approach—combining antimicrobial and anti-inflammatory properties in one molecule with extended half-life—represents a sophisticated peptide engineering strategy for critical care applications.

Questions still open

Could DF2-HSA be effective in viral-induced cytokine storms (e.g., COVID-19)?
What is the therapeutic window for DF2-HSA administration during a cytokine storm?
How does DF2-HSA compare to existing anti-cytokine therapies like tocilizumab?

Common questions

What is a cytokine storm?

A cytokine storm is when the immune system overreacts, flooding the body with inflammatory molecules that damage organs instead of fighting infection. It's a major cause of death in sepsis and severe COVID-19.

How does this peptide help?

DF2-HSA combines a human antimicrobial peptide (defensin) that fights infection with albumin that reduces inflammation and keeps the peptide active longer in the body—addressing both the infection and the harmful immune overreaction.

Read the original research

A Human β-Defensin-Based Recombinant Protein DF2-HSA Ameliorates Cytokine Storm.

Cells, 15(2)

View on PubMed ↗Publisher’s paper ↗

Citation

Du, Yibo; Yu, Zhuojun; Sheng, Weijin; Li, Yi; Hou, Lei; Zheng, Yanbo; Liu, Xiujun; Zhen, Yongsu. (2026). A Human β-Defensin-Based Recombinant Protein DF2-HSA Ameliorates Cytokine Storm.. Cells, 15(2). https://doi.org/10.3390/cells15020202